We describe an approach for the simultaneous determination of isoenzymes of alkaline phosphatase (EC 3.1.3.1) based on the kinetic behavior of inhibition reactions. Data for absorbance vs time, collected while enzymes are being inhibited, are fitted with suitable models to obtain results related to activities of the individual isoenzymes. The primary focus is on two-component mixtures of the bone and liver isoenzymes of alkaline phosphatase, but some results are reported for three-and four-component mixtures. Factors studied include choices of inhibitors, buffers, pH, ionic strength, substrate concentration, kinetic models, data ranges, data densities, and data-processing approaches and programs. Criteria used to select optimal conditions include measurement times, detection limits, useful range, and agreement between expected and computed results for mixtures of isoenzymes. For two-component mixtures, a linear least-squares fit of isoenzyme content computed with the curve-fitting method (y) vs a comparison method (x) gave y = 0.96 (± 0.05)x + 3.8 (± 3)% with r = 0.97 and standard error of the estimate of 9.4% for a range from 15 to 300 U/L. The pooled relative standard deviation (CV) for results was about 5%. Results were degraded for three-and four-component samples. The need exists for a fast, reliable method for determining liver-and bone-type alkaline phosphat.ase (ALP; EC 3.1.3.1) (1) (2) (3) . At present, methods for the isoenzymes involve procedures that are labor intensive (electrophoresis), require specialized instruments (post-column reaction and sometimes special columns for chromatography), or have been shown (4) to have poor precision (selective inhibition). We have investigated a nonlinear regression procedure for simultaneous determinations of liver-and bone-type ALP from combined inhibition responses. Such a procedure would enable one to determine both total and individual isoenzyme activities from a single inhibition response. If a multichannel by using models for one first-order and one zero-order process (10) and two first-order and two zero-order processes (11) in parallel. However, our study differs in that both isoenzymes are completely inhibited at equilibrium.
of the isoenzymes of alkaline phosphatase from inhibition curves is not new. Brown and Lewis (5), PetitClerc (6), Moss and Whitby (7) , and Shepherd and Peake (8) have investigated such procedures. Recently, Lewis and Rutan (9) demonstrated resolution of the two isoenzymes by use of a Kalman filter to resolve inhibition responses and suggested that electrophoretic methods may benefit from similar techniques. For most of these methods, however, bone-type ALP is inhibited so rapidly that it is difficult to monitor time-dependent responses continuously with conventional clinical instrumentation for normal ranges of activities. Although the procedure of Moss and Whitby (7) does not depend on a measurable rate of change for bone-type ALP, this method is less convenient than procedures that require measurements of only one kinetic response. To our knowledge, simultaneous determinations of normal amounts of liver-and bone-type ALP in human sera from combined inhibition responses have been neither optimized nor demonstrated for multipoint kinetic methods. Other studies have demonstrated the use of curve-fitting methods for simultaneous determinations of two isoenzymes by using models for one first-order and one zero-order process (10) and two first-order and two zero-order processes (11) in parallel. However, our study differs in that both isoenzymes are completely inhibited at equilibrium.
Previously, we reported procedures for optimization of inhibition responses by use of simulated, simultaneous first-order data (12). Results of that study indicated that optimum conditions would involve small ratios (2-4) of rate constants and large enzyme activities. Also, the best dynamic range would be obtained if the rate of inhibition were such that the smallest activity of interest for the isoenzyme with the largest rate constant should produce the smallest change in signal that can be measured with desired reliability. To obtain the best reaction conditions, we determined activities and rate constants for three different amino-alcohol buffers and three different inhibitors. The combinations we investigated were urea/2-arnino-2-methyl-1-propanol, urea/diethanolamine, ureai2-(ethylamino)ethanol (EAE), and guanidine hydrochloride/diethanolamine. Inactivation by heat was also evaluated. We used factorial designs extensively because activities and rate constants depend on many additional factors-e.g., pH, substrate concentration, and ionic strength. We investigated the effects of these variables, as well as of buffer and inhibitor concentrations, and determined the best conditions for the curve-fitting method.
We then determined the best fitting procedures from the responses obtained under the chosen conditions. Several different models, fitting ranges, and measurement intervals were evaluated. Predicted activities for best models and measurement procedures were compared with known values for prepared mixtures 
Materials and Methods Reagents
Sources and general methods for preparation of reagents are listed here, but final concentrations for some experiments are given in the discussion of results. We prepared all reagents with distilled, de-ionized water.
Buffers: We used three buffers: 2-ainino-2-methyl-1-propanol (Sigma Chemical Co, St. Louis, MO 63178), EAE (Aldrich, Milwaukee, WI 53233), and diethanolamine (Fluka Chemie AG, CH-9470 Buchs, Switzerland)-all prepared by transferring a specific weight or volume to a volumetric flask, adding aqueous hydrochloric acid or sodium hydroxide until the desired pH was obtained, and diluting with water. Buffer solutions were stored at 4#{176}C.
Inhibitors: We used urea (Fisher Scientific Co., Fair Lawn, NJ), guanidine hydrochloride (Sigma), and sodium chloride (Malhinckrodt, Paris, KY 40361) as inhibitors. We dried the guanidine hydrochloride in an oven at 105 #{176}C for 12 h, then stored it in a desiccator.
Activators:
Activators were magnesium chloride hexahydrate and zinc chloride (both from Mallinckrodt, St. Louis, MO 63160). In one casewe used N-(2-hydroxyethyl)ethylenediamine triacetic acid, trisodium salt dihydrate (HErYFA; Aldrich) to control the metal ion concentrations.
Sub8t rate: Substrate was disodiuni 4-nitrophenyl phosphate (4-NPP; Sigma). We prepared solutions of 4-NPP by diluting a known mass of 4-NPP with buffer or water to a known volume. We stored these solutions in the dark at 4#{176}C and used them for a maximum of four days. Whenever possible, fresh solutions were prepared daily.
4-Nitrophenol solution (4-NP):
We diluted a measured mass (0.1736 g) of 4.-nitrophenol (Sigma) to 250 mL with water. We diluted portions of this stock solution further with water, then mixed them with a substrate/inhibitor solution (one part 4-NP to six parts substrate/inhibitor) for the optimized reaction conditions described later.
Optimal substrate/inhibitor solution: A solution containing 1.2 mol of EAE (pH 10.54 at 25.0 #{176}C), 6.0 mmol of 4-NPP, 0.18 mol of sodium chloride, 1.2 mmol of magnesium chloride hexahydrate, and 1.38 mol of urea per liter was stored in the dark at 4#{176}C and used for a maximum of four days. A 0.833-fold dilution with serum and water gave final concentrations for EAE, urea, sodium chloride, 4-NPP, and magnesium chloride of 1.0, 1.15, 0.15, 5.0 x iO, and 1.0 x iO mol/L, respectively.
Reagents for comparison methods: We prepared buffer, inhibitor, and substrate solutions so that final concentrations were as described by Statland et al. (13) . L-Phenylalanine and Brij 35 (Sigma) solution were used as obtained. Magnesium chloride, diethanolamine, and 4-NPP solutions were prepared as listed above, stored in the dark at 4#{176}C, and used for a maximum of four days. We also prepared buffer and substrate solutions so that final concentrations were as described by Bowers and McComb (14) . Substrate solution (4-NPP) was divided into 1-mL aliquots and stored at -15 #{176}C. Buffer solution was prepared with 2-ainino-2-methyl-1-propanol and stored in the dark at 4#{176}C. Sourcesfor all other reagents required to prepare the buffer and substrate solutions are listed above.
Alkaline phosphatase isoenzymes: Thirty sera were obtained for which we determined total ALP and isoenzyme activities by a procedure similar to a comparison method (13). Other sera (obtained from two sources) had above-normal ALP activity, some with normal y-glutamyltransferase activity; these were thought to contain mostly bone-type ALP. Sera from men, from women in the third trimester of pregnancy, and from subjects with above-normal ALP of unknown origin were provided by a local hospital. AU samples were stored at -15 #{176}C in the dark and thawed for 24 h before use.
We processed some sera having above-normal ALP activity by the heat-inactivation procedure of Moss and Whitby (7) or by the comparison method of Statland et al. (13) ; only those that were least inhibited were assumed to contain primarily the liver-type isoenzyme. Similarly, samples thought to be primarily bone type were rapidly inhibited by urea when processed by either of these methods. Several other samples containing liver-type ALP were prepared by heating sera that contained only liver-and bone-type ALP [as determined by the method of Statland et al. (13)] for 13 mm at 56#{176}C to inactivate the bone-type isoenzyme. Sera from pregnant women were heated at 65#{176}C for at least 30 mm to denature all isoenzymes except the placental type. We prepared samples free of all isoenzymes by heating sera from male subjects for at least 30 mm at 65#{176}C to inactivate all ALP isoenzymes expected to be present (15) . Nine samples containing mixtures of bone-and liver-type ALP were prepared by mixing one-component serum samples, 200 and 50 U/L, respectively, to a total volume of 150 zL. Total activities of the mixtures were quantified in triplicate by the procedure of Bowers and McComb (14) and were used to compute isoenzyme fractions.
Three-and four-component mixtures: Sera containing liver-and bone-type ALP and some that also contained intestinal ALP were mixed with sera that contained placental-type ALP. The activity of the placental-type ALP was about 2% of the total for each mixture.
Instrumentation and Procedures
Kinetic measurements: We obtained kinetic measurements for chemical inhibition by using a centrifugal mixer (Rotochem ila; Aminco, Deerfield, IL). Absorbances were measured at 405 nm with data rates as identified in the text. We placed substrate/inhibitor solutions in the middle wells of the transfer tray, and water and sera together in the inner well of the tray. Trays were warmed at 37#{176}C for 15 miii and placed in the centrifugal mixing system with temperature controlled at 37.0 #{176}C. The first absorbance measurement was made 6-10 s after the spinning process was begun.
We conducted heat-inactivation studies with a diodearray-based spectrophotometer (Model 8450A; HewlettPackard, Palo Alto, CA). Water circulating through the temperature-controlled cuvet holder maintained the reaction temperature.
Models for two components: The nonlinear regression algorithm and most models used to estimate the total signal change and initial velocity have been described previously. We used first-order (17), variable-order (18), combined first-order/zero-order (10, 11), and simultaneous first-order (12) models and a modified (16) simultaneous variable-order model (18). These models are all incorporated into a customized program called KINETrX, written in "C" language.
Initial estimates for the initial signal, S, and steadystate signal, Se,,were the first and last measured signal values, respectively. Rate constants were estimated from values observed for one-component samples, and signal changes, S, were estimated as the last signal measured unless specified otherwise.
Software and Data Processing
Computer: Data obtained from the centrifugal mixer and spectrophotometer were transferred to and processedby a super microcomputer (Masscomp 5500 Work Station; Maascomp, Westford, MA) with a UNIX operating system.
Resolution of liver and bone ALP:
The quantitative resolution of liver and bone ALP was based on the linear relationship between the isoenzyme fraction and the ratios of the total signal change to total initial velocity, For simultaneous first-order reactions, the relationship between S/V0 and isoenzyme fraction is (12,16)
in which f1is the fraction of the initial velocity due to component 1, and k11 and k, are first-order inhibition rate constants for components 1 and 2. Equation 1 indicates that a plot of tiSfV0 will be linear, with a slope of 1/k1,1 -1/k21 and an intercept of 1/k2,1. If rate constants are known, results from one-component solutions can be used to construct a calibration plot from the inverse rate constants or equivalently, S/V0.
Because the bone-type fraction appeared to involve two first-order processes, it was necessary to consider an alternative model. Such a model can be constructed if the second component exhibits a proportional relationship between initial velocity and signal change, S2, for that component. if this linear relationship is expressed as V20 = mS2, then
where m is the proportionality constant between V2,0 and S2. The linear relationship is valid only if the sub-types of the secondcomponent are present in a fixed ratio of concentrations.
Model for three components:
A model was developed for the simultaneous estimation of three-component mixtures of liver-, bone-, and intestinal-type ALP.
where t is time. Partial derivatives are given elsewhere (16) .
Results and Discussion
Activities of all sera were determined by the procedure of Bowers and McComb (14) on the same day that the inhibition experiments were done. For studies of effects of reaction conditions, initial velocities were scaled to 10 UIL to facilitate internal comparisons for different conditions. Sera were diluted 50-fold and values for 4-NPP, magnesium chloride, and temperature were 15 mmol/L and 37#{176}C, unless specified otherwise. Inhibition responses for single components were fitted with use of a first-order or combined zero-order/firstorder model, depending on whether enzymes were completely inhibited or not. Imprecisions are reported as ± 1 SD or as relative standard deviation (RSD, %). Figure 1 shows some typical response curves. The response for intestinal ALP is expected to be similar to that for placental ALP except it curves gradually toward the time axis.
Evaluationof Buffer-InhibitorCombinations
Results were similar for all buffer-inhibitor combinations in the sense that higher concentrations of inhibitors and sodium chloride increased the rates of inhibition and decreased the initial velocities. For higher (1) concentrations of inhibitors, values of initial velocities computed from first-order or first-and zero-order fits to bone-type responses tended to be smaller than for similar activities of liver-type ALP. Also, first-order fits to bone-type responsesappeared to have more scatter and more systematic trends in residuals than did fits to liver-type responses.For all conditions except inhibition by 0.90 moIIL guanidmne hydrochloride, bone-type ALP was inactivated more rapidly than liver type. Ratios of rate constants in the desired range (2-4) and largest initial velocities were observed for inactivation by heat (55 #{176}C) and for the EAE-urea system. Chemical inhibition was expected to be more convenient, sowe chosethe EAE-urea system for more detailed study.
Optimization of the EAE-Urea System
We used single-factor studies to investigate the effects of pH and substrate (4-NPP) concentration. Ionic strength, buffer concentration, and inhibitor concentration were varied in several full-factorial studies for fixed values of pH and 4-NPP concentration. Unless stated otherwise, fixed values of the several variables (molIL) were as follows: sodium chloride (0.9), urea (0.9), EAE (2.0), and magnesium chloride (6.4 X 10-i) with a pH of 10.5 and a temperature of 25.0 #{176}C.
Effects of substrate concentration:
We measured inhibition responses for liver (66 U/L) and bone (138 U/L) ALP to determine the effects of 4-NPP concentration. Two measurements were made for each isoenzyme type and for each of 10 different substrate concentrations from 7.5 through 30.0 mmol/L; other variables were held constant at values given above. Absorbance values were measured at 11-s intervals for 37 mm after mixing.
Substrate concentrations have two main effects on the system. Increased concentrations of 4-NPP increase both enzyme activity and background absorbance. Background absorbances, estimated from the intercepts at t = 0 of linear fits over the first three data points (31 a), increased linearly from 0.47 to 1.2 absorbance units. Trends in activity were evaluated by computing the mean background-corrected absorbance (19) between 2144 and 2199 s. For both isoenzymes, activities increased for substrate concentrations up to 18 mmol/L and remained constant for larger concentrations. For many of the remnining studies, the 4-NPP concentration was 17 mmol/L so as to obtain the highest activities possible. Ultimately, however, we chose 5 mmol/L substrate to reduce effects of background and reduced the dilution factor for sera from 50-fold to 30-fold to compensate for the reduced activity resulting from the lower substrate concentration.
Effects ofpH: We investigated the effects of pH for the same conditions as described above except that magnesium chloride and 4-NPP concentrations were 1.0 and 17.0 mmol/L, respectively. Two inhibition responses were obtained for liver and bone ALP for each of 11 different values of pH (9.08-10.72 at 25#{176}C). Absorbances were measured at 11-or 6-s intervals for the liver and bone types, respectively, with total measurement times of 37 and 20 mm, respectively. Rate constants were estimated from first-order fits over all the available data. Initial velocities were estimated from fits with a first-order model to the initial part (34-304 a) of each response.
Effects of pH on rate constants and enzyme activities are shown in Figure 2 for bone-type ALP. Rate constants increased gradually for pH values of 9 to 10.3, then increased very rapidly, with slopes of in k vs pH being near 1.0 and 3 at low and high pH, respectively. Initial velocities appeared to reach a nlRTimum for pH near the expected value of 10.0-10.2 (20) .
Effects were similar for liver-type ALP.
Although a pH near 10.2 would give highest activities, higher values would increase inhibition rate constants to values (about 5 x 1O s') that were expected to be best for this system. The final choiceof pH was not made at this point. Instead, pH was included as an additional factor in a series of factorial designs described elsewhere (16).
Optimal conditions: Details of several levels of factorial designs used to identify near-optimal conditions are described elsewhere (16). A major criterion was to find conditions for which k = in which V is the minimum velocity to be quantified and b.S,, is the smallest signal that can be measured reliably. It was shown earlier (12) that this condition should lead to the widest possible dynamic range of activities. We used a rather conservative value of = 0.05 to arrive at recommended conditions. A grid search of factorial results allowed us to identify several combinations of variables that satisfied this condition. From those, we selected the set of conditions that gave the largest Inhibition responses for final conditions: Typical responses for three isoenzyme types are illustrated in Figure 1A . Bone-and liver-type ALP have approximate values for rate constants of 4 x 1O and 1.9 x iO sW', respectively, and both are more than 98% inhibited after about 2200 s. Placental-type ALP remnins uninhibited under these conditions. In Figure 1B , intestinaltype ALP causes the continuing gradual increase in absorbance at longer times.
Data-Processing Options
Here we summarize results of extensive studies (16) designed to optimize operational options for quantifying the liver and bone fractions in two-component mixtures of these isoenzymes.
Background effects: Time-dependent changes in absorbance were observed in the absence of ALP. A fast initial increase was followed by a gradual, exponential decrease. The change, superimposed on an average background of 0.31, varied from 0.012 to 0.029, with an average of 0.020 for seven different heat-inactivated sera. Substrate (4-NPP) was observed to cause the initial increase. The exponential decrease is thought to be mainly an effect of serum components because the decrease for a solution containing all reagents except serum or substrate, but with 8.3 psnol/L 4-NP, was only 20% to 40% of the decrease observed when heat-inactivated serum was present. Serum components such as hemoglobin and bilirubin are known to absorb at this wavelength (21) and photodegradation of bilirubin as well as denaturation of hemoglobin in strongly basic solution has been reported (15).
Inhibition responses of prepared mixtures were corrected for background effects by point-by-point subtraction of the responses for heat-inactivated sera. When background correction was omitted, the coefficient of determination for computed vs true activity decreased from 0.973 to 0.650 and the standard error of the estimate increased 3.5-fold.
Curve-fitting models: Initial studies were done with single-component samples. Figure 3 shows typical experimental and fitted response curves obtained with first-order and variable-order models. Both models fit the data reasonably well, as indicated by the fact that experimental and fitted plots are virtually superimposed. The more systematic residuals associated with the first-order fit to the bone-type response were reduced significantly by fitting a two-component first-order model to these data. However, the resulting threecomponent model that would be required for mixtures would involve seven fitting parameters, which we judged to be impractical for a variety of reasons, including longer data-processing times and more ambiguous resolution of the two primary components. Accordingly, subsequent studies of mixtures were done with simultaneous two-component first-order and variable-order models. Table 1 summarizes results for several two-component mixtures. We used two versions of each model. In one version of each, five variables, including rate constants, were evaluated by the curve-fitting process;in the other version, rate constants were held at fixed values evaluated for single-component samples, and only three variables were evaluated by the curve-fitting process.
The performance of each option was evaluated by a linear least-squares fit of AS/V0 vs the fraction, f1,of the bone type (see equation 1) and by comparing standard errors of the estimates for fits to the inhibition response curves. Results in Table 1 show that the simultaneous first-order model with all five variables evaluated in the curve-fitting process gives the best correlation between fits of AS/V0 vs 11 and the smallest residuals in the curve-fitting process.We chosethis as the model for all subsequent studies. Note that improved correlation between AS/V0 and 11 can be obtained by evaluating V0 from data near the origin and AS from data after the inhibition processes are complete (16) . However, this involves considerably longer measurement times than the curve-fitting process described here.
Other models evaluated were less satisfactory than the four options included in Table 1 .
Fitting range: Eleven different fitting ranges that included these first 2.4 to 9.7 half-lives were evaluated. Best correlation of AS/V0 vs isoenzyme fraction was obtained for a fitting range of 7.5 half-lives of the liver type and this range was used for subsequent studies. For this range, the pooled standard error of estimate corresponded to 5.5% variations in isoenzyme content relative to a value of 5% calculated for prepared mixtures. An F-test for lack of fit indicated that the linear model (AS/V0 vs f1)is satisfactory.
Initial estimates:
The curve-fitting process requires initial estimates of fitting parameters to be quantified (see Table 1 ). Although wide ranges of initial estimates for the different fitting parameters were evaluated, the best results were obtained for initial estimates of S0 29 taken as the first value measured, AS1 and AS2 taken as 50% of the maximum value measured, and rate con-6.2 stants equal to values determined for individual isoenzymes. Except in extreme cases, the curve-fitting processis relatively insensitive to initial estimates. Data density: Data densities ranging from 10 to 60 data points over 7.5 half-lives were evaluated. As long as data rates were selected such that 70% of the data points were collected during the first two half-lives of the process, results were relatively insensitive to the number of data points used for the fitting range of 7.5 half-lives. As few as 10 data points gave reliable results.
Performance Charactenstics
Primary focus is on two-component mixtures but some results for three-component samples are discussed briefly.
Dynamic range: The linear range for each isoenzyme was determined separately by using three replicate measurements of each of 11 dilutions of each isoenzyme in heat-inactivated serum. Activities were determined reliably for ranges of 0.59 to 158 U/L for liver type and of 2.9 to 322 U/L for bone type. Activities of 204 and 368 U/L for the liver-and bone-type isoenzymes, respectively, produced final absorbances >2.35, which exceeded the useful range of the photometer used. The detection limits were estimated to be 5 and 9.4 U/L for liver-and bone-type ALP, respectively. Smaller activities (0.59 and 2.9 U/L, respectively) gave estimates for AS/VOwith relative standard deviations of 30%, which is much larger than the pooled relative standard deviation (7.8%) for higher activities. We concluded that the linear ranges for this method are 5-158 U/L and 10-322 UIL for the liver and bone types, respectively. The combined range, defined as the useful range for an unknown serum regardless of whether it contains a mixture or single component, is 10-158 UIL.
Imprecision: Imprecision was estimated by a twostage nested analysis of variance design. Replicate measurements of the same liver-type-containing serum were made at 0, 1.47,3.83,20.1, and 44.9 h. This design was chosen because total variation can be partitioned into within-run, within-day, and day-to-day variations (15) , with appropriate degrees of freedom for the unbalanced design.
The results of this experiment are shown in Table 2 . For computed values of AS/V0 and activity, respectively, the overall relative standard deviations were 6.4% and 8.8% and are much larger than the within-run standard deviations, 4.1% and 3.9%. Results from the analysis of variance show that the differences between total and within-run variations are due to variations between runs. Day-to-day variations were smaller than variations between runs by three-to fourfold (data not shown). This is the reason the sum of within-run, run-to-run, and day-to-day variation is larger than the overall computed variance, and this effect is probably an anomaly due to the small number of experiments.
Effects of sample-to-sample variation on the calibration plot for isoenzyme content were investigated by making three runs each of three different liver-and bone-type sera. These results are summarized in Table  3 . For liver ALP, overall imprecision was 5.4% and appeared to be evenly distributed between variations within and between different samples. Overall impreci- lIver, 598 U/I; bone, 194 U/I. b Sum of wlthin-sera and serum-to-serum. 0Computedfrom all data. sion was larger for bone ALP (6.9%) and was entirely due to variations among replicates.
Method comparison:
Total activity and isoenzyme content for 25 different sera thought to contain little or no intestinal ALP were processed by the curve-fitting and comparison (13) methods. We made three sets of measurements for each serum by the nonlinear regression method and one determination by the comparison procedure. Activities ranged from 15 to 300 U/L, and all measurements were made on the same day. Although the results do not appear to show proportional or additive bias, the standard error of the estimate indicates that agreement is only within ± 9.4%, which is about twofold the imprecision determined from the replicates (5% on average). Quantities obtained from the fitting process were the signal changes (AS1, AS2, AS3) and rate constants (k1,1,h2,1,k3,1) for the three processes, where subscripts 1-3 represent the bone, liver, and intestinal fractions, respectively.
The initial velocity for the intestinal fraction was estimated as V0,3 = AS3k3,1.Fractions of bone and liver types were evaluated by using equation 1 as described above. The total initial velocity was calculated as V0 = k1,1 AS1 + k2,1 AS2 + k3,1 AS3.
The model was evaluated for 42 different serum samples. These included 13 samples thought to contain up to 15% intestinal ALP and four samples to which 2% placental-type ALP had been added. Estimates of total activity and isoenzyme content were regressed against results from a comparison method (13). Also, pooled relative standard deviations for the estimates were computed from the replicates. These results are summfirized in Table 4 .
Correlations with the comparison method were best for estimates of total activity. The correlation was reasonable (0.99) and the standard error of the estimate was 22.8, or about 9.5% of the mean activity for these samples. Results were worse for estimates of isoenzyme content. Inaccuracy and imprecision increased for samples containing only bone-and liver-type ALP, and intestinal ALP was not determined reliably.
We considered whether the method might be used to detect, rather than to quantify, a third component. The method detected a third component in 11 of the 17 samples that contained intestinal, placental, or a combination of these types of ALP. For the six samples in which the third component was not detected, the type was intestinal and the mean content, determined by the comparison procedure, was 2.5%. The procedure found intestinal ALP (3%) in two cases for which none was expected. These results suggest that the method can be used to detect concentrations of intestinal ALP >2.5% and low concentrations of placental ALP (2%).
The nonlinear regression method produces reasonably precise estimates of total activity and isoenzyme content for both prepared and unknown serum samples containing two components (liver and bone ALP). Relative standard deviations for total activity are only about 2% higher for this method than for comparison methods that do not include inhibitors in the reaction. Plots of computed vs comparison values for activities appeared to be linear and unbiased. Isoenzyme content is estimated within ±6% and ± 9.4% for prepared and unknown mixtures, respectively. Imprecisions were 5-6% in both cases, and the large value for standard errors (9.4%) for the regression of computed against comparisonvalues may be due to imprecision in the comparison method. This statement is supported by the fact that the nonlinear regression results were unbiased and that the comparison method has been reported to be imprecise due to propagation of errors to the final result (4). The limiting factor for the accuracy of the curve-fitting method is the variation in values of AS/V0 for onecomponent samples needed to make calibration plots for isoenzyme content. The method is marginally useful, at best, for three-component samples. 
